Form 4: Beyond Air Director Acquires Warrants, Amends Terms

Beyond Air Director Robert Carey reports acquiring new warrants and amending existing ones, tied to a $2 million loan to the company.

Summary

• Beyond Air, Inc. Director Robert Carey acquired warrants to purchase 512,821 shares of Common Stock at an exercise price of $1.95 per share.
• This acquisition was in connection with a $2,000,000 loan provided by the Reporting Person to Beyond Air, Inc.
• The warrants are exercisable on or after their issuance date of November 3, 2025, and will expire five years from that date.
• An outstanding warrant for 494,332 shares was amended, resulting in the cancellation of the 'old' warrant with an exercise price of $7.586 and the issuance of a replacement warrant with an exercise price of $1.95.
• The amended warrant was originally issued on September 27, 2024, became exercisable on November 22, 2024, and will expire five years from November 22, 2024.
• Following these transactions, Robert Carey beneficially owns 512,821 newly acquired warrants and 494,332 amended warrants, all directly held.

Sentiment

Score: 6

Explanation: The capital infusion from the director's loan is a positive for the company's liquidity. However, the significant repricing of existing warrants to a lower exercise price, while facilitating the loan, could be viewed as a negative signal regarding the company's previous valuation or future prospects by some investors, balancing the overall sentiment to moderately positive.

Positives

• A Director provided a $2,000,000 loan to Beyond Air, Inc., injecting capital into the company.
• The Director's acquisition of new warrants demonstrates continued commitment and alignment with the company's future performance.

Negatives

• The amendment of existing warrants involved a significant reduction in the exercise price from $7.586 to $1.95, which could indicate a re-evaluation of the company's stock value or a need to offer more favorable terms to secure financing.
• The issuance of new warrants and the amendment of existing ones represent potential future dilution for existing shareholders if exercised.

Risks

• Potential dilution of existing shareholders' equity if the newly acquired and amended warrants are exercised.
• The repricing of warrants could signal underlying concerns about the company's stock performance or valuation.

Future Outlook

na

Industry Context

This Form 4 filing details an insider transaction, which is specific to the company and its director, rather than reflecting broader industry trends. It indicates a director's direct financial involvement and commitment to the company.

Related Party Transactions

• Director Robert Carey provided a $2,000,000 loan to Beyond Air, Inc. and received warrants in connection with this transaction, constituting a related party dealing.

Stakeholder Impact

• Shareholders: Potential for dilution from the exercise of warrants, but also benefit from the capital infusion provided by the loan.
• Company: Receives $2,000,000 in capital, improving liquidity and financial flexibility.

Next Steps

• The newly acquired warrants will be exercisable on or after November 3, 2025, and will expire five years thereafter.
• The amended warrants will expire five years from November 22, 2024.

Key Dates

Keywords

Beyond Air, XAIR, Warrants, Insider Transaction, SEC Form 4, Director, Capital Raise, Loan, Equity, Dilution